As per attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The company reported revenue from operations of ₹938.45 lakhs for Q2 FY26, up about 4% from ₹901.52 lakhs in Q2 FY25. For the half year (H1 FY26), revenue from operations grew nearly 20% to ₹1,885.82 lakhs versus ₹1,573.74 lakhs in H1 FY25, helped by an uptick in patient admissions and surgery volumes. Profit after tax rose modestly to ₹63.58 lakhs (H1 FY26) from ₹58.97 lakhs (H1 FY25), translating to EPS of ₹1.94 (basic). However, operating cash flow swung sharply negative to ₹(250.65) lakhs in H1 FY26, reflecting higher receivables and inventory build-up. EBITDA margin compressed to about 10.4% from 12.8% a year ago, and short-term borrowings jumped to ₹427.31 lakhs from ₹108.83 lakhs at March-end.
Revenue growth is decent but profit growth is lagging, margins are under pressure, and the company is burning cash from operations while taking on more short-term debt — a combination that may concern investors despite the topline improvement.